CANCELLED - SECTION 8
section 8
on 11 Oct 2013
Last Applicant/ Owned by
4002
Basel
CH
Serial Number
78670229 filed on 14th Jul 2005
Registration Number
3214868 registered on 06th Mar 2007
Filing Basis
No Filing Basis
Disclaimer
NO DATA
CAPIDIOV
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area an Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals
Mark Details
Serial Number
No 78670229
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 51653
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Oct 2013 | CANCELLED SEC. 8 (6-YR) |
| 21st Jun 2009 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 06th Mar 2007 | REGISTERED-PRINCIPAL REGISTER |
| 19th Dec 2006 | PUBLISHED FOR OPPOSITION |
| 29th Nov 2006 | NOTICE OF PUBLICATION |
| 31st Oct 2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| 27th Oct 2006 | ASSIGNED TO LIE |
| 26th Oct 2006 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 24th Oct 2006 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 13th Oct 2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |